My PCR
Create Account
Logo PCR

17 Nov 2025

LAA closure

LAA closure is evolving: are you ready?

Sponsored by Boston Scientific

Anchorperson: J. E. Nielsen-Kudsk
Spokesperson: J. Camm
SHOW MORE

Summary

This session addresses the evolving landscape of left atrial appendage (LAA) closure in stroke prevention for atrial fibrillation patients. It reviews unmet clinical needs, evaluates the latest evidence and guideline recommendations, and identifies patient populations that benefit most from LAA closure, with discussions on balancing efficacy and safety and optimizing post-procedural management.

Learning Objectives

  • To recognise the unmet needs in stroke prevention for patients with atrial fibrillation
  • To interpret the latest clinical evidence and guideline recommendations on left atrial appendage closure
  • To identify patient populations who derive the greatest benefit from left atrial appendage closure
Related Content
Selection of top Late-breaking Trials presented at #PCRLV Left atrial appendage occlusion The next frontier in LAA closure: innovations and opportunities
Recommended for you
GulfPCR-GIM 2025 – What's on the Programme? Register now for GulfPCR-GIM 2025 OPINION trial